ABSTRACT
INTRODUCTION
The World Health Organisation reported in 2011 that about 30% of worldwide deaths were caused by cardiovascular diseases. Compared with past data, rates of death from cardiovascular diseases have declined in most developed countries because of improved awareness and timely treatment. By contrast, people in developing countries are more prone to cardiovascular diseases because of various reasons. ST-segment elevation myocardial infarction (STEMI) has high morbidity and mortality as a common and severe presentation of cardiovascular diseases. Annually, more than 3 million people suffer or die from STEMI worldwide. 1 Restoring coronary flow and reperfusing myocardial tissue 2, 3 as early as possible is currently proven as the key link to the treatment of STEMI. 4, 5 For these patients, saving time is saving life. Fast transport and timely treatment are both paramount. However, reperfusion delay has become an urgent worldwide problem to be solved, especially for developing countries.
Retrospective studies [6] [7] [8] show that the factors associated with longer time to treat STEMI vary in different areas. In China, reperfusion delay has existed for long time, but large-scale research in this area is scarce. Among the several known studies, non-systematic reasons are prevalent 9, 10 
Statistical analysis:
The data were presented as mean±standard deviation ( ±s), and the means of the groups were compared by ANOVA and q-test. The statistical significance level was p<0.05 (twosided test). All data were processed by SPSS 13.0 statistical software package.
RESULTS

Reperfusion time of primary percutaneous coronary intervention:
The comparison between Group 1 and Group 2 in Time periods 1, 2 and 3 had no statistical significance (P>0.05) ( Table-I ). Time periods 4 and 5 of Group 1 were significantly shorter than those of Group 2 (P<0.05) ( Table-II) . Group 3 had no primary percutaneous coronary intervention cases. In patients receiving primary percutaneous coronary intervention, the door-to-balloon time of Group 1 was 172±13 minutes and that of Group 2 was 251±14 minutes. The hospitals in both groups took more than 90 minutes, taking too much time to obtain consent and prepare the treatment.
Revascularisation time of thrombolysis treatment:
The comparison between Group 1 and Group 2 in the time of symptom onset, first medical contact, diagnosis, providing consent, start of therapy and reperfusion time had no statistical significance. The time of providing consent and the time from symptom onset to first medical contact Group 3 were significantly longer than those of Groups 1 and 2 (P<0.05) ( Table-III) . In patients receiving primary thrombolysis treatment, the door-to-thrombolysis time of Group 1 was 86±7 minutes, that of Group 2 was 91±7 minutes and that of Group 3 was 123±11 minutes. The times of the three groups all exceeded 30 minutes and were mainly spent in obtaining consent.
DISCUSSION
In the past two decades, the diagnosis and treatment of STEMI has been remarkably enhanced. 11, 12 The successful launch of primary percutaneous coronary intervention has led to the decrease in STEMI mortality from 30% to less than 5%. 13, 14 The cardiovascular branch of the Chinese Medical Association developed the 2010 STEMI diagnosis and treatment guidelines based on the ACC/AHA treatment guidelines of STEMI that was updated in 2009, 15 with the core idea of achieving reperfusion as early as possible. 3 This strategy requires the emergency department to complete the clinical examination within 10 min for patients with suspected AMI, record the monitor 18-lead ECG (conventional 12 leads plus V7 to V9 and V3R to V5R) and interpret it. Pharmacological reperfusion should be performed within 30 minutes or PCI within 90 minutes. However, the primary percutaneous coronary intervention time of patients with STEMI is evidently delayed. 16, 17 Recent surveys show that the door-to-balloon time is borderline with regard to the guidelines for only 19% of patients.
2,3
The economic and medical levels of Henan Province, which has a population of over a hundred million, are domestic mid-stream so the primary revascularization time of Henan Province can reflect the overall situation in China. Unlike other studies, this manuscript is an accurate reflection of the actual situation in the country. In this study, we set the boundaries as symptom onset, first medical contact, diagnosis, providing consent, start of therapy (the beginning time of medication in thrombolytic therapy or the vascular puncture time in emergency percutaneous coronary intervention) and reperfusion time (the time of meeting the reperfusion standards in thrombolytic therapy or the time of balloon dilatation in emergency percutaneous coronary intervention) and recorded the time from symptom onset to first medical contact, the time of diagnosis, the time of providing consent (from the diagnosis to providing consent, including the communication time of illnesses' state, the time of explaining treatment schedules and the time of making decisions), the time of the start of therapy (from providing consent to the start of treatment, which can be divided into the time for patients' family to prepare the surgery cost and medical preparation time) and the time from the start of treatment to the patency time. Among these boundaries, the times for providing consent and treatment preparation are unique in our country. 9, 18 In addition, we looked at a lot of foreign medical literature in the developing countries, but the related research has not been found. In terms of Time period 1, the time of patients in treatment in the three groups was visibly longer than that reported in foreign developed countries. The time of patients in treatment in the country hospitals was the longest; this finding indicates the differences in various aspects, such as scientific quality, patients' willingness, medical conditions and creation of an emergency rescue system. Time period 2 met the guideline requirements because of the strong feasibility of the STEMI guidelines. Time period 3 cannot be found in foreign literature and guidelines. However, it is an objective reality in China that has existed for an extended time period, and it restricts the reperfusion time into a shorter period. To solve this problem, China should improve the quality of human science and doctorpatient relationships, extend the healthcare reform and solve the problems in cost of the treatment. Time period 4 can be divided into 4A and 4B. 4A denotes the time period for the patients' families to pay the cost of surgery. No such time period is recorded in foreign literature, but this period is also an objective reality in China and has existed for a long time. Nevertheless, China should not only solve the patients' worry about social health insurance but also effectively implement the system of prioritising who gets treated first. 4B is the time period that involves the medical preparation time, which also does not exist in foreign literature. This period usually delays the reperfusion time considerably 19 mainly because most hospitals lack 24hour medical staff and the catheter laboratory is occupied. The fundamental solution 20, 21 is to build catheter laboratories for primary percutaneous coronary intervention and require the personnel to be on duty for 24 hour. In terms of Time period 5, Group 1 recorded a shorter time than Group 2.
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In patients received in-hospital fibrinolytic therapy, the delays of providing consent in Group 3 were longer than those in Groups 1 and 2. In addition to the reasons mentioned above, the communication skills of doctors are also an important factor.
Notably, no case of pre-hospital thrombolysis was reported in this group of patients. Moreover, no case of communication about the reperfusion was found during their transfer to the hospitals; this aspect also requires improvement.
Limitations: This study aimed to investigate the reperfusion time of patients with STEMI based on the part of the provincial, municipal and county hospitals in Henan province, to a certain extent, so the result may be affected by the influence of the geographical, economic, cultural and medical resources. Then, it cannot fully represent the overall treatment level of developing countries. In addition, because it is a retrospective study, clinical features of some cases such as height, waist circumference, body mass index were not documented and detail analyzed. Moreover, this study was not undertaken with strict follow-up.
Overall, the primary percutaneous coronary intervention time of STEMI was clearly longer than that in foreign developed countries 23, 24 and as required in guidelines 9 because of both patients and hospitals. The former was mainly caused by prehospital delay, consent delay and medical cost delay; the latter mainly caused by the lack of 24 hour open catheter laboratory and medical staff, low medical technology level and the unimplemented policy of getting treatment first. This issue must be solved by expanding the healthcare reform and improving the quality of human science, medical technology level and doctor-patient relationship. Therefore, in terms of China's national conditions, the door-to-balloon time is not applicable. We suggest re-defining this time as the first medical contact-diagnosis time, providing consent time, therapy preparation time and start of therapy-balloon time to comply with the actual work in various aspects of the clinical, research, teaching, quality control and policy formulation in this field as well as to meet the needs of this specialty.
